priority drugs or biological products
(2) The term “priority drugs or biological products” means a drug or biological product that is the subject of a drug or biologics application referred to in section 101(4) of the Food and Drug Administration Modernization Act of 1997.
Source
21 USC § 356-1(d)(2)
Scoping language
None identified, default scope is assumed to be the parent (part A) of this section.